Atlas Trials

A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease

Clinical trial NCT04736628 · COMPLETED

Trial details

NCT number
NCT04736628
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2021-04-27
Primary completion
2023-08-15
Enrollment
261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.